Information  X 
Enter a valid email address

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

By BFN News | 08:10 AM | Wednesday 22 January, 2020

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1930p (from 1890p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t